GlaxoSmithKline to produce Combivir in China
BY Advocate.com Editors
November 27 2002 12:00 AM ET
British pharmaceutical company GlaxoSmithKline on Sunday submitted an application to China's State Drug Administration to produce the combination anti-HIV pill Combivir locally in Tianjin, China. If approved, Glaxo will be the first international drugmaker to manufacture an anti-HIV drug in China. The Tianjin plant would be able to start producing Combivir by the end of 2004. The domestically produced medication would cost significantly less than imported versions of the two-drug combination pill, Glaxo officials said. Combivir contains the nucleoside reverse transcriptase inhibitors 3TC and AZT.
- WATCH: The 12 Gayest Holiday Spectaculars Ever!
- These Couples Prove Love Is Love
- 13 Classic Companies Top HRC's New Corporate Equality Index
- Op-ed: What I Didn't Learn in Catholic School
- Salvation Army 'Does Not Consider Homosexual Orientation a Sin'
- WATCH: We Wish Every Coming Out Got a Hug-a-Thon Like This
- Women New Family Ties: Meredith Baxter Marries Nancy Locke December 09 2013 8:01 PM
- Travel Spider-Man Will Welcome In 2014 In Times Square December 09 2013 7:52 PM
- Election Is Marriage Equality Still Politically Dangerous, Even in Mass.? December 09 2013 7:09 PM
- Entertainment News Tig Notaro Nominated for Best Comedy Album December 09 2013 6:08 PM
- HIV & AIDS Republican Pol: Gays Want Free Medical Care Because of AIDS December 09 2013 6:04 PM
- Parenting Israel Again Deals Gay Couples, Families Legislative Setback December 09 2013 4:10 PM
- Business America's Best Places to Work, According to HRC December 09 2013 3:49 PM